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Double-stranded DNA (dsDNA) in the cytosol is a dangerassociated molecular pattern that triggers inflammation and immune responses. Cytosolic DNA can be derived from viral or intracellular microbial infections, undigested phagocytosed materials, and activated self-retroelements (1) . The presence of cytosolic DNA is detected by several cellular sensors, which in turn initiate signaling cascades to induce inflammatory response and type I interferon production (2) . Despite the redundancy between these cytosolic DNA sensors, cyclic GMP-AMP synthase (cGAS) 3 is the predominant sensor relaying the presence of cytosolic DNA to downstream signaling cascades (3) . Upon binding to dsDNA, cGAS produces cyclic 2Ј-3Ј GMP-AMP (cGAMP), which serves as a second messenger to activate the endoplasmic reticulum adaptor protein stimulator of interferon genes (STING) (3) (4) (5) (6) . Activation of STING by cGAMP leads to STING oligomerization, followed by recruitment and activation of TANK-binding kinase 1 (TBK1) (7, 8) . Subsequently, TBK1 phosphorylates interferon regulatory factor 3 (IRF3) to promote expression of interferons (IFNs), thereby initiating immune responses to establish an antiviral state (7, 9, 10) . In addition to IRFs, other transcription factors, including nuclear factor B (NF-B) and signal transducer and activator of transcription 6 (STAT6), are also activated by STING and TBK1 downstream of cytosolic DNA (11) (12) (13) (14) .
The transcription factor STAT3 is activated by tyrosine 705 phosphorylation downstream of a variety of cytokines, such as epidermal growth factor (EGF) and IL-6 (15) . Phosphorylation at tyrosine 705 leads to nuclear accumulation of STAT3 homodimers and expression of target genes containing a ␥-activated site (GAS) in their promoters (16) . STAT3 drives the expression of prosurvival and inflammatory genes, and sustained activation of STAT3 has been shown to promote proliferation, enhance survival of neoplastic cells, and facilitate inflammation-driven tumorigenesis (17) (18) (19) . In addition to its role in promoting tumorigenesis, STAT3 also represses the anti-tumor activity of hematopoietic cells, making it a key candidate for targeted cancer therapy and immunotherapy (20, 21) . STAT1, another STAT family member, predominantly functions downstream of interferons. STAT1 homodimers induced * This work was supported by National Institutes of Health (NIH) Grants AI35098 and R35CA197684 (to A. S. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. □ S This article contains supplemental Figs. 1-3. 1 Present address: AbbVie, Inc., 1 N. Waukegan Rd., North Chicago, IL 60064. 2 To whom correspondence should be addressed: 450 by IFN␥ recognize almost identical GAS sites as STAT3 dimers do in vitro, but STAT1 and STAT3 have different, albeit overlapping, target genes in vivo (22) . On the other hand, type I IFNs, including IFN␣ and IFN␤, induce the formation of not only the STAT1 homodimer but also the interferon-stimulated gene factor 3 (ISGF3) complex comprising STAT1, STAT2, and IRF9. The ISGF3 complex promotes the expression of genes containing an IFN-stimulated response element (ISRE) in their promoters (23) . Reciprocal antagonizing effects between STAT1 and STAT3 can be observed in certain scenarios (24) . For example, STAT3 inhibits STAT1-dependent induction of ISRE genes in response to type I IFN stimulation presumably through STAT1-STAT3 heterodimerization (25) . Whereas dimerization and activity of STAT proteins are controlled by tyrosine phosphorylation, recent studies have demonstrated that the function of STATs can also be modulated by TBK1 and the closely related kinase IB kinase ⑀ (IKK⑀). Phosphorylation of STAT1 at Ser 708 by IKK⑀ disrupts STAT1 homodimerization and favors ISGF3 formation, thereby shifting the type I IFN-induced gene expression profile from GAS-driven genes to ISRE-driven genes (26) . Cytosolic nucleic acids and viral infections engage the STING-TBK1 pathway, leading to TBK1-mediated phosphorylation of STAT6 at Ser 407 and STAT6 activation (14) . Interestingly, functional loss of cGAS or STING has been observed in colorectal cancer and melanoma and correlates with disease progression and elevated STAT3 activation (27) (28) (29) , suggesting a role of STING in restricting STAT3 activity and tumor progression. Thus, we sought to determine whether activity of STAT3 can be regulated by the STING-TBK1 pathway downstream of cytosolic DNA. Here we show that STAT3 is activated by cytosolic DNA through an autocrine mechanism involving IFN␤ and IL-6. At the same time, cytosolic DNA activates TBK1 in a cGAS-and STING-dependent manner to directly phosphorylate STAT3 at serine 754 in the transactivation domain (TAD). This TBK1-mediated phosphorylation at Ser 754 is inhibitory and restrains cytosolic DNA, IL-6, and IFN␤-induced activation of STAT3. Our finding provides a possible explanation for the role of STING in limiting STAT3 activation and further emphasizes the complex signaling cascades and gene expression initiated by cytosolic DNA.
Results

TBK1 Directly Phosphorylates STAT3 at Serine 754 -Previ-
ous studies demonstrated that TBK1 and IKK⑀, respectively, regulate the function of STAT6 and STAT1 by direct phosphorylation (14, 26) . To determine whether TBK1 and IKK⑀ also phosphorylate other STATs, we examined the sequences of STATs against the optimal substrate motif for TBK1 and IKK⑀ (30, 31) and identified serine 754 in the TAD of STAT3 as a potential TBK1/IKK⑀ phosphorylation site (Fig. 1A) . To test whether STAT3 is a substrate of TBK1 or IKK⑀, IKK⑀ and STAT3 were overexpressed in HEK293T cells, and immunoprecipitated STAT3 was blotted with an IKK family phosphosubstrate motif antibody (see "Experimental Procedures"). Overexpression of wild-type IKK⑀ strongly induced phosphorylation of STAT3 at Tyr 705 as well as a site recognized by the IKK phosphosubstrate motif antibody (Fig. 1B) . We then generated an antibody specific for phospho-Ser 754 -STAT3 and repeated the experiment with TBK1. Similarly, overexpression of wild-type, but not kinase-dead, TBK1 induced STAT3 phosphorylation at multiple sites, and S754A mutation of STAT3 abolished the signal of Ser(P) 754 -STAT3-specific antibody (Fig.  1C) , suggesting that TBK1 kinase activity is critical for the phosphorylation of STAT3 at Ser 754 . Overexpression of TBK1 and IKK⑀ in HEK293T may lead to activation of other kinases, which in turn phosphorylate STAT3. To determine whether TBK1 is capable of phosphorylating STAT3 directly, we performed an in vitro kinase assay with purified TBK1 and recombinant GST-STAT3 from bacteria. Autoradiography showed that incubation with wild-type but not kinase-dead TBK1 led to strong phosphorylation on wild-type STAT3 and that S754A mutation of STAT3 abolished the phosphorylation (Fig. 1D) . This TBK1-mediated phosphorylation on STAT3 was also recognized by the Ser(P) 754 -STAT3-specific antibody (Fig. 1D) . These data show that TBK1 is capable of directly phosphorylating STAT3 at Ser(P) 754 (Fig. 2B) . Poly(dA:dT) transfection induced association of STAT3 with TBK1 and IKK⑀, whereas VACV70mer induced association of STAT3 with TBK1 but not IKK⑀ (Fig. 2B ). These stimuli also induced various degrees of IKK␣/IKK␤ activation and p65 phosphorylation, indicative of NF-B activation (Fig. 2B) . Finally, a time course experiment revealed that association between TBK1 and STAT3 was induced as early as 1.5 h after dsDNA transfection, coinciding with the timing of Ser 754 phosphorylation, whereas Tyr 705 phosphorylation of STAT3 was detected at a later time point (Fig.  2C) . Taken together, these data show that among different TBK1 activators, cytosolic DNA induces the most robust STAT3 activation and phosphorylation at Ser 754 . TBK1 Is Required for Cytosolic DNA-induced STAT3 Phosphorylation at Ser 754 -Given that cytosolic DNA induces robust TBK1 activation, STAT3 phosphorylation, and association between TBK1 and STAT3, we asked whether TBK1 is required for cytosolic DNA-induced Ser 754 phosphorylation of STAT3. We found that STAT3 Ser 754 phosphorylation and IRF3 phosphorylation were abrogated with genetic ablation of TBK1 or siRNA-mediated TBK1 knockdown (Fig. 3, A and B) . On the other hand, IKK⑀ knockdown had negligible effects on STAT3 Ser 754 or IRF3 phosphorylation (Fig. 3C ), indicating that TBK1 but not IKK⑀ is required for cytosolic DNA-induced STAT3 phosphorylation. It has been shown that cytosolic DNA also activates IKK␣ and IKK␤ (Fig. 2B) (13) and that the optimal substrate motif of IKK␣ and IKK␤ shares a partial homology to that of TBK1 and IKK⑀ (30, 31, 34, 35) . To further investigate the role of individual IKKs in promoting STAT3 phosphorylation upon cytosolic DNA challenge, we used an IKK␣/IKK␤-specific inhibitor compound A (36) and two TBK1/IKK⑀-specific inhibitors, AZ-5C and AZ-5E (37) . The TBK1/IKK⑀ inhibitors blocked the induction of phospho-IRF3 and Ser(P) 754 -STAT3, whereas phospho-p65 was mostly unaffected (Fig. 3D) . Tyr 705 phosphorylation of STAT3 was also dependent on TBK1 and/or IKK⑀ (Fig. 3D ). In contrast, the IKK␣/IKK␤ inhibitor potently blocked the induction of phospho-p65 but had minimal effect on phospho-IRF3, Ser(P)
754
-STAT3, or Tyr(P) 705 -STAT3 in THP-1 cells (Fig. 3D) (Fig. 4B) . We also tested whether the cytosolic dsDNA sensor cGAS is required in this setting. Knockdown of cGAS led to reduced activation of TBK1 and phosphorylation of IRF3 and a moderate reduc- 754 -STAT3 may be due to incomplete knockdown of cGAS or the redundancy of other cytosolic DNA sensors. Activation of cGAS by cytosolic DNA leads to production of cGAMP, which subsequently promotes STING activation and activation of the TBK1-IRF3 signaling axis. We found that transfection of cGAMP is sufficient to induce Ser 754 phosphorylation of STAT3 (Fig. 4D) , further supporting the model in which Ser 754 phosphorylation of STAT3 occurs downstream of STING. These data demonstrate that cytosolic DNA engages cGAS and STING to activate TBK1 and induce STAT3 Ser 754 phosphorylation.
Secreted Cytokines Induce Activation of STAT3 in Response to Cytosolic DNA-We next set out to determine the mechanism of STAT3 activation (as marked by Tyr 705 phosphorylation) in response to cytosolic DNA. In THP-1 cells, activation of STAT3 was suppressed by TBK1/IKK⑀ inhibitors ( Fig. 3D) , suggesting that TBK1 kinase activity is required for STAT3 activation. Because TBK1 is not a tyrosine kinase, activation of STAT3 is probably mediated by tyrosine kinases that are directly or indirectly activated by TBK1. It is well established that Janus kinases (JAKs) activate STAT3 by phosphorylating Tyr
705
. We thus asked whether JAKs are involved in STAT3 activation in response to cytosolic DNA. Treating the cells with a pan-JAK inhibitor, pyridine 6 (39), effectively blocked STAT3 phosphorylation at Tyr 705 , but TBK1 activation and phosphorylation of STAT3 at Ser 754 was unaffected (Fig. 5A ). These data and the TBK1 inhibitor data (Fig. 3D ) suggest that cytosolic DNA-induced STAT3 activation is primarily mediated by JAKs, the activation of which is dependent on TBK1. Because JAKs usually function downstream of cytokine receptors, we hypothesized that cytosolic DNA induces production of cytokines, leading to activation of the JAKs and STAT3 through an autocrine mechanism. An alternative hypothesis would be that TBK1 activates JAKs directly or through a cascade of kinase activation in a cell-autonomous manner. To test these hypotheses, we asked whether conditioned media from dsDNA-transfected cells are able to activate STAT3 in naive recipient cells. We A, L929 cells were transfected with poly(I:C), poly(dA:dT), or VACV70mer (hereafter referred to as dsDNA) using Lipofectamine 2000; treated with 1 g/ml LPS; or serum-starved for 3 h. Lysates were analyzed by Western blotting to determine the levels of TBK1, IRF3, and STAT3 activation. B, THP-1 cells were treated as described in A or treated with 1 g/ml flagellin for 3 h. Lysates were analyzed by Western blotting, and STAT3 was immunoprecipitated (IP) and blotted for co-precipitated IKK⑀ or TBK1. C, a time course analysis of signaling responses to cytosolic DNA. THP-1 cells were mock-transfected or transfected with dsDNA and analyzed by Western blotting at the indicated times. STAT3 was immunoprecipitated and blotted for Ser(P) 754 and co-precipitated TBK1. Data in this figure are representative of two independent experiments.
found that conditioned media from dsDNA-transfected THP-1 strongly induced Tyr(P) 705 -STAT3 but not Ser(P) 754 -STAT3 in the recipient cells (Fig. 5B, lanes 10 -14) . When cells were treated with cycloheximide immediately before dsDNA transfection to block protein synthesis, the ability of conditioned media to induce Tyr(P) 705 -STAT3 in the recipient cells was abrogated (Fig. 5B, lanes 15-18) . Although the possibility of cell-autonomous TBK1-mediated JAK activation cannot be completely ruled out because a weak STAT3 activation was still observed in cycloheximide-treated cells (Fig. 5B, lanes 6 -9) , these results argue that STAT3 activation is primarily mediated by de novo synthesized secreted factors. We noticed that expression of several STAT3-activating cytokines, including IL-6 and IFN␤, was induced by cytosolic DNA, and the induction of IFN␤ was blunted by TBK1 inhibitor (supplemental Fig. 1 ). Therefore, we tested the involvement of IL-6 and IFN␤ in STAT3 activation. Indeed, an IFN␤-neutralizing antibody reduced the ability of conditioned media to activate STAT3 in the recipient cells, and an IL-6-neutralizing antibody also had a modest effect (Fig. 5C) (Fig. 6A ). STAT1 and p65 were also activated by cytosolic DNA, but their activation was not affected by the status of STAT3, and p65 showed constitutive association with STAT3 (Fig. 6A) . We also examined the gene expression induced by cytosolic DNA. STAT3 target gene SOCS3 was up-regulated in the presence of STAT3 (Fig. 6B) , and its expression was further elevated in the S754A cells, consistent with increased activation of the S754A mutant (Fig. 6A) . The NF-B target gene IL6 was also up-regulated in the presence of STAT3, but Ser 754 phosphorylation did not have any measurable effect on its expression (Fig. 6C) . This suggests that there may be cooperative binding and transcriptional activation between STAT3 and NF-B in regulating IL-6 transcription, but Ser 754 phosphorylation of STAT3 does not affect the gene expression mediated by this complex. In agreement with this hypothesis, the interaction between p65 and STAT3 was not affected by cytosolic DNA or the status of Ser 754 phosphorylation (Fig. 6A) . We also asked whether Ser 754 phosphorylation of STAT3 modulates the inhibitory effect of STAT3 on ISGF3 target genes (25) and found that CXCL10 was downregulated by wild-type and mutant STAT3 to similar levels (Fig.  6D) , suggesting that Ser 754 phosphorylation is not involved in the inhibition of ISGF3 target genes by STAT3. Finally, chromatin immunoprecipitation demonstrated that upon cytosolic DNA challenge, STAT3 was recruited to the predicted binding sites in SOCS3 promoter (Fig. 6E) and that the increased abundance of S754A STAT3 at the SOCS3 promoter correlated with gene expression levels (Fig. 6B ). These data demonstrate that cytosolic DNA-induced Ser 754 phosphorylation of STAT3 dampens the expression of STAT3 target gene without affecting the expression of NF-B or ISGF3 genes.
Ser 754 Phosphorylation Suppresses the Transcriptional Activity of STAT3-Because Ser 754 is located in the transactivation domain of STAT3, we hypothesized that phosphorylation at Ser 754 modulates the transcriptional activity of STAT3 in response to IL-6 and IFN␤. We asked whether Ser 754 phosphorylation of STAT3 affects the expression of a STAT reporter containing tandem GAS sites in response to IFN␤ and IL-6 by using a phosphomimetic mutant (S754D), because Ser 754 phosphorylation is not induced by IFN␤ or IL-6 alone. To avoid interference from endogenous STAT3, the reporter assay was carried out using CRISPR-mediated STAT3 knock-out HEK293T cells (supplemental Fig. 2 ) or STAT3-null MEFs stably expressing wild-type or mutant STAT3. We found that IFN␤ induced a much higher expression of the STAT reporter in the presence of wild-type STAT3, but the transcriptional inactive Y705F mutant inhibited reporter expression (Fig. 7A) , indicating that STAT3 contributes to GAS-driven gene expression in response to IFN␤. The reporter expression was reduced with the S754D mutant, suggesting an inhibitory role for Ser 754 phosphorylation in the transcriptional activity of STAT3 (Fig.  7A) . In contrast, STAT3 did not affect GAS-driven gene expression in response to IFN␥ (Fig. 7A) , which predominantly activates STAT1 but not STAT3 (15) . The S754D mutant also showed decreased activation upon IFN␤ stimulation (Fig. 7B) , consistent with the results from reporter assays. We then asked whether TBK1-induced Ser 754 phosphorylation affects STAT3 activation in response to IFN␤. Because overexpression of TBK1 leads to significant production of cytokines, resulting in elevated basal STAT3 activation (40) (Fig. 1C) , here we expressed a moderate amount of TBK1 before treating the cells with IFN␤. We found that TBK1 expression suppressed IFN␤-induced STAT3 activation, but the S754A mutant was more refractory to this TBK1-mediated inhibition (Fig. 7C, lanes 5  and 7) . These data show that Ser 754 phosphorylation inhibits IFN␤-induced activation of STAT3. We also probed the possibility that Ser 754 phosphorylation of STAT3 may affect STAT3-mediated inhibition on ISGF3 target genes. Consistent with CXCL10 expression in THP-1 cells (Fig. 6D) , wild-type and mutant STAT3 inhibited IFN␤-induced ISRE reporter expression to comparable levels (supplemental Fig. 3 ), indicating that Ser 754 phosphorylation of STAT3 does not affect ISGF3 activity. Similar to the IFN␤ reporter assays, S754D mutant was also less active in response to IL-6 as measured by STAT reporter assays and by the levels of Tyr 705 phosphorylation, which inversely correlated with the levels of Ser 754 phosphorylation or phosphomimetic mutation (Fig. 7, D and E) . Collectively, these data demonstrate that Ser 754 phosphorylation suppresses the transcriptional activity of STAT3 induced by IL-6 and IFN␤.
Discussion
In this study, we identified STAT3 as a novel substrate of TBK1 downstream of the cytosolic DNA pathway. In the presence of cytosolic DNA, TBK1 phosphorylates STAT3 at Ser 754 to limit STAT3 activity induced by cytokines, such as IL-6 and IFN␤. Previously, it has been shown that IKK⑀ regulates STAT1 dimerization and that TBK1 regulates STAT6 activity by direct phosphorylation (14, 26) . Our finding places a third STAT member under the control of IKK⑀/TBK1. Interestingly, the IKK⑀/TBK1-mediated phosphorylation sites in STAT1, STAT3, and STAT6 differ in their location within the proteins (Fig. 1A) . In the case of STAT1, phosphorylation of Ser 708 , which resides between the SH2 domain and the TAD, disrupts SH2 domain-mediated STAT1 homodimerization by steric hindrance (26) . How TBK1-mediated Ser 407 phosphorylation regulates the activity of STAT6 is less clear. Ser 407 resides within a highly conserved region of the STAT DNA binding domain, and structural analysis demonstrated that mutations in this region abolish the DNA binding ability of STATs (41) . Thus, it is plausible that Ser 407 phosphorylation affects the DNA binding affinity of STAT6. It is also worth noting that TBK1 induces a reduced but still significant phosphorylation on STAT6 S407A mutant (14) , suggesting the existence of additional TBK1 phosphorylation sites in STAT6. In fact, we identified another IKK⑀/TBK1 substrate motif in STAT6 TAD, in which Ser 733 is the residue that corresponds to Ser 754 of STAT3. Our preliminary data suggest that TBK1 overexpression also leads to STAT6 phosphorylation at Ser 733 . 4 For future investigations, it would be of interest to determine whether this phosphorylation serves as an additional mechanism by which TBK1 regulates STAT6 activity in a manner similar to what we discovered with STAT3.
The two IKK-related kinases TBK1 and IKK⑀ are structurally similar and prefer almost identical substrate sequences in vitro (30, 31) . However, they appear to have distinct yet partially overlapping roles in vivo (42) . Studies using TBK1 or IKK⑀ knock-out cells showed that TBK1 is the principle kinase that phosphorylates IRF3 to initiate interferon production in response to innate immune stimuli and pathogens, whereas IKK⑀ has a minor or negligible role in activating IRF3 and interferon production (11, 43, 44) . Similarly, in our model, although overexpression of TBK1 and IKK⑀ both induced Ser 754 phosphorylation of STAT3 (Fig. 1, B and C) , endogenous IKK⑀ did not have a measurable impact on STAT3 phosphorylation in response to VACV70mer (dsDNA with 33% GC content) transfection (Fig. 3C) . However, it is worth noting that whereas VACV70mer only induced interaction between STAT3 and TBK1, poly(dA:dT) transfection induced interaction of STAT3 with TBK1 and IKK⑀ (Fig. 2B) , suggesting that IKK⑀ may contribute to the signaling cascades and STAT3 phosphorylation downstream of AT-rich cytosolic DNA. AT-rich cytosolic DNA not only activates the STING-TBK1 pathway but also engages the cytosolic dsRNA sensor RIG-I by a polymerase IIIdependent mechanism (45) . Thus, the differential interactions between STAT3 and IKK⑀/TBK1 in response to VACV70mer and poly(dA:dT) may be due to the activation of cytosolic dsRNA pathway specifically downstream of poly(dA:dT). It is also conceivable that IKK⑀ will play a more dominant role in scenarios where its expression is highly induced (46) . Whether IKK⑀ contributes to STAT3 Ser 754 phosphorylation and regulation under these conditions remains to be tested.
The NF-B pathway is also activated by cytosolic DNA, but the roles of different IKKs in this context remain controversial (11-13). Ishii et al. (11) suggested that TBK1 is dispensable for 4 H.-C. Hsia, unpublished observation. (Fig. 3, A and  D) , indicating that the signaling events dictating NF-B and IRF3 activation diverge at or above the level of these kinases. Intriguingly, p65 activation in L929 is mostly dependent on TBK1 (Fig. 3B) , consistent with the observation made by Abe et al. (13) . It is unclear why such differences exist. One possible explanation may be the availability of different signaling molecules and the formation of different complexes. For instance, depending on the cell type, TBK1 may localize to the mitochondria or the endoplasmic reticulum in response to cytosolic DNA (47) . Therefore, it is likely that signaling pathways downstream of cytosolic DNA and STING may be influenced by the availability of cell type-specific machinery and platforms as well as the subcellular localization of TBK1.
Although it is unclear why Ser 754 phosphorylation dampens the activity of STAT3, studies on a natural occurring STAT3 Relative quantity TBK1 Regulates STAT3 Activity in Response to Cytosolic DNA isoform STAT3␤ provide a plausible hypothesis. Alternative splicing of the STAT3 transcript results in the truncated STAT3␤ isoform that is 48 amino acids shorter than the fulllength STAT3 (48) . STAT3␤ shows strong Tyr 705 phosphorylation and DNA binding activity even in the absence of stimulation, but it lacks intrinsic transcriptional activity due to the lack of TAD (48, 49) . Interestingly, STAT3␤ dimers are more stable than dimers formed by full-length STAT3, and deletion of 19 residues at the C terminus (amino acids 752-770) of fulllength STAT3 is sufficient to significantly enhance Tyr 705 phosphorylation, DNA binding activity, and dimer stability (50) . Because the C terminus of STAT3 is rich in acidic amino acids that are negatively charged, it was therefore proposed that the cluster of negative charges in the TAD interferes with STAT3 dimerization and makes phosphorylated Tyr 705 more accessible to phosphatases (50) . Given this mechanism, phosphorylation or phosphomimetic mutation of Ser 754 will introduce more negative charges to the region and may destabilize STAT3 dimers, thereby reducing its transcriptional activity. Alternatively, it is also possible that Ser 754 phosphorylation affects the interaction between STAT3 and its co-activators to modulate STAT3 activity. Future studies will focus on testing these hypotheses.
There is mounting evidence of the critical role of cytosolic DNA in tumorigenesis and anti-tumor immune responses. Functional loss of the cGAS-STING cytosolic DNA pathway has been observed in some commonly used cell lines and high passage immortalized MEFs (5) as well as colorectal cancer and melanoma, in which loss of the cytosolic DNA pathway correlates with tumor progression (27, 28) . In a mouse model of colitis-associated colorectal cancer, STING-deficient mice showed elevated NF-B and STAT3 activity and developed advanced disease, suggesting a role of STING in controlling inflammatory responses and tumorigenesis (29) . According to our model, loss of the cytosolic DNA sensing pathway will predict loss of the TBK1-mediated restraint on STAT3 activity, allowing the tumor cells to have elevated STAT3 activation in response to cytokines such as IL-6. Given the well established role of STAT3 in promoting tumorigenesis, our finding suggests a possible mechanism in which tumor cells without the cytosolic DNA pathway may have a survival advantage due to unchecked STAT3 activation. On the other hand, activation of dendritic cells in the tumor microenvironment by engaging the cGAS/STING pathway leads to significant T cell recruitment and anti-tumor immunity (51, 52) . Because STAT3 negatively regulates dendritic cell activity and the anti-tumor response of hematopoietic cells (20, 53) , cytosolic DNA-mediated restraint on STAT3 activity may serve as an additional mechanism to strengthen the anti-tumor immunity of hematopoietic cells in the tumor microenvironment.
In summary, we identified a novel signaling axis in which TBK1 modulates STAT3 activity in response to cytosolic DNA. Our findings reveal a new mechanism by which the activity of STAT3 can be fine-tuned by a single phosphorylation and shed light on the possible cross-talk between innate immune responses and STAT3-driven oncogenic pathways.
Experimental Procedures
Plasmids and Viruses-Mouse STAT3 was cloned into pBabe-puro (Addgene, catalog no. 1764) (54) using BamHI and EcoRI. N-terminal HA-tagged STAT3 was cloned into 3XHA-pEBB vector using BamHI and NotI. N-terminal FLAG-tagged STAT3 was cloned into pENTR-3C plasmid using BamHI and EcoRI, followed by Gateway recombination into pLenti6/ UbC/V5 destination vector (Thermo Fisher). The C terminus of STAT3 (amino acids 700 -770) was cloned into pGEX-4T-1 in frame with N-terminal GST using BamHI and EcoRI. STAT3 mutant plasmids were generated by site-directed mutagenesis and confirmed by sequencing. STAT3 CRISPR plasmid was constructed using lentiCRISPRv2 (Addgene, catalog no. 52961) (55) with a single guide RNA targeting the 5Ј-UTR of human STAT3 (supplemental Fig. 2 ). The primer sequences for single guide RNA cloning are as follows: 5Ј-CAC CGT GCC GGA GAA ACA GGT GAA G-3Ј and 5Ј-AAA CCT TCA CCT GTT TCT CCG GCA C-3Ј.
Protein Purification and in Vitro Kinase Assay-Rosetta cells (Novagen) harboring pGEX-4T-1-STAT3 plasmid were grown to log phase and treated with 0.5 mM isopropyl ␤-D-1-thiogalactopyranoside at 30°C for 16 h. The cells were lysed (50 mM Tris, pH 7.6, 150 mM NaCl, 1 mM EDTA, 5 mM DTT, 25 g/ml lysozyme, protease inhibitor mixture (Promega)) at room temperature, followed by the addition of 1.25 g/ml sodium deoxycholate, 1.25 M MgCl 2 , and 62.5 g/ml DNase I. Cleared lysates (13,000 rpm, 15 min, 4°C) were incubated with glutathione-agarose beads (Amersham Biosciences) at 4°C for 2 h. The beads were washed twice with modified RIPA buffer (150 mM NaCl, 1% Nonidet P-40, 0.25% sodium deoxycholate, 50 mM Tris, pH 7.6, 1 mM ␤-glycerol phosphate), twice with high salt (500 mM NaCl) modified RIPA, and twice with kinase buffer (1 mM ␤-glycerol phosphate, 20 mM Tris, pH 7.4, 12 mM MgCl 2 ). Wild-type and K38A GST-TBK1 were purified from HEK293T transfected with pEBG-GST-TBK1 plasmids as described previously (31) . For in vitro kinase assays, 1-2 l of purified GST-STAT3 was incubated with 2-4 l of wild-type GST-TBK1 or K38A GST-TBK1 in kinase buffer with 1 mM ATP and 10 Ci of [␥- 32 P]ATP at room temperature for 2 h. The reaction was resolved by SDS-PAGE, followed by immunoblotting or autoradiography.
Cells-THP-1 cells were maintained in RPMI1640 with 10% FBS, whereas HEK293T, L929, and MEFs were maintained in DMEM with 10% FBS and kept at 37°C with 5% CO 2 . STAT3-null MEFs were a gift from Dr. Hua Yu (City of Hope), and TBK1 null MEFs were a gift from Amgen. Retroviruses were produced by co-transfection of pBabe-puro-STAT3 and pCL10A1 plasmids into HEK293T cells, and lentiviruses were produced by co-transfection of pLenti6-STAT3 with psPAX2 and pMD2.G into HEK293T cells. The supernatants containing viruses were 0.45 m-filtered before being used for transduction. To reconstitute STAT3 expression in STAT3-null MEFs, MEFs were transduced with pBabe-puro-STAT3 retroviruses and selected for puromycin resistance. To generate STAT3 CRISPR knock-out cells, THP-1 or HEK293T cells were transduced with STAT3 CRISPR virus and selected for puromycin resistance, and single clones were analyzed for STAT3 knockout efficiency (supplemental Fig. 2 ). To reconstitute STAT3 in THP-1, ⌬STAT3-THP-1 cells were transduced with pLenti6-STAT3 viruses and selected for blasticidin resistance.
To activate TBK1, cells were transfected with poly(I:C), poly-(dA:dT), VACV70mer, or 2Ј-3Ј cGAMP using Lipofectamine 2000 (Thermo Fisher) at a 1:1 ratio (g/l), and the final concentration of nucleic acids was 2 g/ml unless otherwise noted. THP-1 cells were treated with 25 ng/ml phorbol 12-myristate 13-acetate (Sigma, P1585) overnight to induce adherence before cytosolic DNA transfection. Poly(I:C) (tlrl-pic) poly(dA: dT) (tlrl-patn), cGAMP (tlrl-cga23), and LPS (tlrl-eblps) were from Invivogen. VACV70mer was prepared by annealing complementary 70-nucleotide primers as described previously (33) . For experiments with conditioned media, supernatants from nucleic acid transfected cells were collected and 0.2 m-filtered; mixed with 20 g/ml normal mouse IgG (Millipore, 12-371), 20 g/ml human IL-6-neutralizing antibody (R&D Systems, MAB206), or 40 g/ml human IFN␤ neutralizing antibody (BioLegend, catalog no. 514004); and incubated at room temperature for 20 min before being added to recipient cells.
Transfection of siRNA-Transfection of siRNA was carried out using Lipofectamine 2000 according to the manufacturer's protocol. Mouse Tbk1 (M-063162-01-0005), mouse Ikbke (IKK⑀) (M-040798-01-0005), mouse Tmem173 (STING) (M-055528-01-0005), and control siRNAs (D-001210-03-05) were from Dharmacon. Mouse Mb21d1 (cGAS) siRNA was from Sigma (SASI_Mm01_00129826)
Reporter Assay-The STAT reporter 4xM67 pTATA TKfirefly luciferase plasmid (Addgene, catalog no. 8688) (56) and pRL-TK-Renilla luciferase plasmid (Promega) were co-transfected at 15:1-20:1 ratios into ⌬STAT3 293T cells together with 4xHA-STAT3 plasmids. Twenty-four hours after transfection, cells were treated with 25 pg/ml mouse IFN␤ (R&D Systems, 8499-IF-010) or 200 pg/ml mouse IFN␥ (R&D Systems, 285-IF-100). Cells were lysed with passive lysis buffer (Promega) for the Dual-Luciferase assay (Promega) at 16 -24 h after treatment. The relative luciferase units (RLU) were calculated by normalizing the reading of firefly luciferase to that of Renilla luciferase, and RLU of the control cells was set to 1. For IL-6 reporter assays, STAT3 reconstituted MEFs were transfected with reporters in the same manner and treated with 100 ng/ml mouse IL-6 (BioLegend, catalog no. 575704) for 24 h.
Immunoblotting and Immunoprecipitation-For immunoblotting, cells were lysed in RIPA buffer with protease inhibitor mixture (Promega), phosphatase inhibitor mixture (Sigma), and 1 mM Na 3 VO 4 . Cleared lysates were resolved by SDS-PAGE (NuPAGE bis-tris gels, Thermo Fisher), transferred to PVDF membranes (Millipore, IPVH00010), and blocked in 5% nonfat milk in TBST. The membranes were incubated in primary antibodies (1:1000 -1:5000) in TBST at 4°C overnight, washed with TBST, and incubated in appropriate HRP-conjugated secondary antibodies (Promega) (1:10,000). Pierce ECL (Thermo Fisher) was added to the blots, which were then exposed to films and developed or imaged using ChemiDoc (Bio-Rad). For immunoprecipitation, cells were lysed in 0.5% Nonidet P-40 buffer (0.5% Nonidet P-40, 150 mM NaCl, 20 mM Tris, pH 7.6, 1 mM EGTA, 1 mM EDTA, 1 mM ␤-glycerol phosphate, and 0.5% glycerol) with protease and phosphatase inhibitors and Na 3 VO 4 . Cleared lysates were incubated with M2 FLAG (Sigma) or STAT3 antibodies at 4°C overnight, followed by incubation with Dynabead protein G (Thermo Fisher) for 1 h at 4°C and washing with 0.5% Nonidet P-40 buffer, and resolved by SDS-PAGE and immunoblotting. (30, 31, 34, 35) . GAPDH (sc-25778) and ␤-tubulin (sc-9104) antibodies were from Santa Cruz Biotechnology, Inc. Densitometry analyses were carried out using the gel analysis function of ImageJ.
Chromatin Immunoprecipitation-Chromatin immunoprecipitation (ChIP) was performed as described previously (57) . Briefly, cells were fixed by formaldehyde, lysed, and sonicated to yield DNA fragments of 200 -500 bp. Lysates were diluted to 0.1% of SDS and precleared by incubating with BSA and salmon sperm DNA-blocked Dynabead magnetic protein G beads (Thermo Fisher). Lysates corresponding to 5 ϫ 10 6 cells were used for each ChIP with 5 g of rabbit IgG (Cell Signaling Technology, catalog no. 2729) or rabbit anti-STAT3 antibody (Cell Signaling Technology, catalog no. 12640), followed by capture with Dynabead magnetic protein G beads. DNA-protein-antibody complexes were eluted, and DNA was uncross-linked and purified by phenol-chloroform. The quantity of input DNA was determined by Nanodrop. The quantity of DNA corresponding to the STAT3 binding site in the SOCS3 promoter in immunoprecipitated chromatin was determined by qRT-PCR with three technical repeats using SYBR Green (Thermo Fisher) and the following primers: 5Ј-TAA GAA GGC TGA TTT CTG GCA GAG G-3Ј and 5Ј-CCA GGT CGG CCT CCT AGA ACT-3Ј. Data are shown as mean with S.D. and are representative of two independent experiments.
Quantitative Real-time PCR-Total RNA from cells were purified using the Qiagen RNeasy Plus kit according to the manufacturer's protocol. 1-2 g of RNA was used to synthesize cDNA using Moloney murine leukemia virus reverse transcriptase (Thermo Fisher). Quantitative real-time PCR (qRT-PCR) was carried out using synthesized cDNA and standard TaqMan probes, primers, and reagents (Thermo Fisher). The expression level of target genes was calculated by the ⌬⌬Ct method relative to the level of GUSB. Data shown are the relative quantity, with the relative quantity of the control cells set to 1.
Statistical Analysis-For reporter assays and qRT-PCR, data are shown as mean with S.D. or mean with 95% confidence intervals, respectively. Each data point was from three technical replicates. Analyses were done by Prism (GraphPad Software, Inc., La Jolla, CA) using a t test with false discovery rate controlled at 1%.
Inhibitors and Reagents-The IKK␣/IKK␤-specific inhibitor Compound A was a generous gift from Dr. Karl Ziegelbauer (Bayer). The TBK1/IKK⑀-specific inhibitors AZ-5C and AZ-5E were synthesized by Dr. Stephen Frye's group at the University of North Carolina (Chapel Hill, NC). The pan-JAK inhibitor pyridone 6 was from Millipore (catalog no. 420099), and cycloheximide was from Sigma (C7698).
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